Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure

<div>Comparison of immunoglobulin (Ig), complements, and survival between antinuclear antibody positive and negative patients with HBV-ACLF. (a) Comparison of IgG and IgM and complement C3 and C4. (b) Kaplan–Meier survival analysis between ANA (+) and ANA (−) groups during 90-day follow-up.</div>

Canadian Journal of Gastroenterology and Hepatology

fig2

Figure 2

Figure 2: Presence of Serum Antinuclear Antibodies Does Not Impact Outcomes in HBV-Related Acute-on-Chronic Liver Failure 